Robert Faure

Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.

Barry I. Posner, Robert Faure, J.W. Burgess et al. · Journal of Biological Chemistry · 1994 · 537 citations · Full text

Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice.

Daniel Zalko, A M Soto, Laurence Dolo et al. · Environmental Health Perspectives · 2002 · 200 citations · Full text

Pregnant Cd1 Mice, Metabolic Remodeling, Toxicological Mechanism +17

Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-γ-triggered JAK2 activation

Julie Blanchette, Nathalie Racette, Robert Faure et al. · European Journal of Immunology · 1999 · 158 citations · Full text

The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis

Marie-Julie Dubois, Sébastien Bergeron, Hyo‐Jeong Kim et al. · Nature Medicine · 2006 · 156 citations

Molecular Physiology, Signal Transduction, Biochemistry +9

The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase(s).

Robert Faure, Gerardo Baquiran, John Bergeron et al. · Journal of Biological Chemistry · 1992 · 140 citations · Full text

Cellular Physiology, Insulin Signaling, Signaling Pathway +20